Greenline Partners’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.48M Sell
52,802
-1,935
-4% -$51.5K 0.16% 83
2025
Q4
$1.36M Buy
54,737
+1,935
+4% +$48.8K 0.16% 90
2025
Q3
$1.35M Sell
52,802
-1,845
-3% -$45.5K 0.16% 89
2025
Q2
$1.32M Sell
54,647
-671
-1% -$15.6K 0.18% 87
2025
Q1
$1.4M Sell
55,318
-7,666
-12% -$201K 0.2% 81
2024
Q4
$1.67M Hold
62,984
0.23% 79
2024
Q3
$1.82M Sell
62,984
-2,057
-3% -$60K 0.26% 73
2024
Q2
$1.84M Sell
65,041
-4,461
-6% -$123K 0.28% 71
2024
Q1
$1.93M Sell
69,502
-701
-1% -$19.5K 0.31% 65
2023
Q4
$2.02M Sell
70,203
-13,704
-16% -$414K 0.34% 62
2023
Q3
$2.78M Sell
83,907
-2,782
-3% -$98.4K 0.52% 48
2023
Q2
$3.18M Sell
86,689
-2,733
-3% -$106K 0.59% 47
2023
Q1
$3.65M Sell
89,422
-5,623
-6% -$243K 0.7% 39
2022
Q4
$4.87M Sell
95,045
-39,552
-29% -$1.9M 0.96% 34
2022
Q3
$5.89M Sell
134,597
-40,908
-23% -$1.99M 1.34% 21
2022
Q2
$9.2M Buy
175,505
+5,371
+3% +$274K 1.99% 13
2022
Q1
$8.81M Sell
170,134
-1,424
-0.8% -$73.9K 1.65% 19
2021
Q4
$10.1M Buy
171,558
+6,940
+4% +$344K 1.91% 13
2021
Q3
$7.08M Buy
164,618
+17
+0% +$753 1.48% 20
2021
Q2
$6.45M Sell
164,601
-1,725
-1% -$67.1K 1.32% 22
2021
Q1
$6.03M Buy
166,326
+17,983
+12% +$638K 1.32% 21
2020
Q4
$5.46M Sell
148,343
-8,080
-5% -$296K 1.25% 23
2020
Q3
$5.45M Buy
156,423
+82,132
+111% +$2.88M 1.39% 23
2020
Q2
$2.3M Sell
74,291
-549
-0.7% -$18.7K 0.61% 52
2020
Q1
$2.32M Sell
74,840
-44,314
-37% -$1.51M 0.75% 44
2019
Q4
$4.43M Sell
119,154
-11,804
-9% -$420K 1.11% 29
2019
Q3
$4.46M Buy
130,958
+8,101
+7% +$295K 1.28% 29
2019
Q2
$5.05M Buy
122,857
+683
+0.6% +$27.1K 1.59% 22
2019
Q1
$4.92M Sell
122,174
-125,286
-51% -$5.02M 1.61% 24
2018
Q4
$10.3M Hold
247,460
3.23% 9
2018
Q3
$10.3M Sell
247,460
-1,770
-0.7% -$68.1K 3.23% 9
2018
Q2
$8.58M Sell
249,230
-5,630
-2% -$192K 2.81% 15
2018
Q1
$8.58M Buy
254,860
+21,015
+9% +$722K 2.85% 14
2017
Q4
$8.04M Buy
+233,845
New +$7.97M 2.67% 16

Other funds holding PFE